Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A9 (FAM90A9) is a gene classified as a primate-specific pseudogene, originating from multiple gene duplications and rearrangements within the FAM90A family. It does not encode a characterized protein and is not considered an active therapeutic target. Pseudogenes like FAM90A9 may play roles in gene regulation, for example, acting as decoys for microRNAs or producing regulatory RNAs, but no specific biological or clinical function has been established for FAM90A9 in the literature to date. There are no known drugs or biomarkers associated with this gene, nor is it implicated in any specific disease pathways. FAM90A9 aliases commonly append "P" to indicate pseudogene status, and database entries frequently note its unclear functional status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A9 (FAM90A9).